Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 18.26% is 145% above its 5-year average of 7.45%, near the high end of its 5-year range (-39.65%–30.75%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.89% below its 12-month average of 21.71%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 18.26%.
RETURN ON INVESTED CAPITAL (ROIC)
18.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
21.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
17.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-14.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-43.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.89%
CURRENT VS 3Y AVG
+2.32%
CURRENT VS 5Y AVG
+144.94%
CURRENT VS 10Y AVG
+224.68%
CURRENT VS 15Y AVG
+141.76%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 725 covered companies
CURRENT VS SECTOR MEDIAN
+154.50%
vs the sector median at left
Puma Biotechnology, Inc.
Market Cap
$486.60M
Return on Invested Capital (ROIC)
18.26%
TTM Avg
21.71%
3Y Avg
17.84%
5Y Avg
7.45%
Market Cap
$479.07M
Return on Invested Capital (ROIC)
-2.19%
TTM Avg
-24.50%
3Y Avg
-28.59%
5Y Avg
-24.45%
Market Cap
$495.09M
Return on Invested Capital (ROIC)
-39.63%
TTM Avg
-67.88%
3Y Avg
-87.45%
5Y Avg
-79.46%
Market Cap
$495.23M
Return on Invested Capital (ROIC)
-15.54%
TTM Avg
-22.63%
3Y Avg
-32.48%
5Y Avg
-46.23%
Market Cap
$474.59M
Return on Invested Capital (ROIC)
-1.08%
TTM Avg
-7.18%
3Y Avg
-14.01%
5Y Avg
-19.76%
Market Cap
$473.84M
Return on Invested Capital (ROIC)
-27.22%
TTM Avg
-25.30%
3Y Avg
-27.88%
5Y Avg
-30.72%
Market Cap
$473.09M
Return on Invested Capital (ROIC)
6.95%
TTM Avg
6.49%
3Y Avg
4.50%
5Y Avg
4.55%
Market Cap
$502.20M
Return on Invested Capital (ROIC)
-34.79%
TTM Avg
-53.61%
3Y Avg
-51.25%
5Y Avg
-40.96%
Market Cap
$469.98M
Return on Invested Capital (ROIC)
-13.15%
TTM Avg
-33.80%
3Y Avg
-80.16%
5Y Avg
-71.70%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Puma Biotechnology, Inc. (PBYI) | $486.60M | 18.26% | 21.71% | 17.84% | 7.45% |
| Arvinas, Inc. (ARVN)vs › | $479.07M | -2.19% | -24.50% | -28.59% | -24.45% |
| Oculis Holding AG (OCS)vs › | $495.09M | -39.63% | -67.88% | -87.45% | -79.46% |
| Evolus, Inc. (EOLS)vs › | $495.23M | -15.54% | -22.63% | -32.48% | -46.23% |
| Cerus Corporation (CERS)vs › | $474.59M | -1.08% | -7.18% | -14.01% | -19.76% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $473.84M | -27.22% | -25.30% | -27.88% | -30.72% |
| Kamada Ltd. (KMDA)vs › | $473.09M | 6.95% | 6.49% | 4.50% | 4.55% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $502.20M | -34.79% | -53.61% | -51.25% | -40.96% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $469.98M | -13.15% | -33.80% | -80.16% | -71.70% |
| Sight Sciences, Inc. (SGHT)vs › | $468.47M | -29.50% | -37.63% | -38.70% | -37.47% |
ROIC
18.3%
ROE
19.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 18.26% |
| 2026-03-31 | 17.14% |
| 2025-12-31 | 20.58% |
| 2025-09-30 | 21.81% |
| 2025-06-30 | 30.75% |
| 2025-03-31 | 24.06% |
| 2024-12-31 | 19.05% |
| 2024-09-30 | 19.61% |
| 2024-06-30 | 11.21% |
| 2024-03-31 | 14.98% |
| 2023-12-31 | 18.82% |
| 2023-09-30 | 14.30% |
| 2023-06-30 | 14.30% |
| 2023-03-31 | 17.42% |
| 2022-12-31 | 9.02% |
| 2022-09-30 | -6.86% |
| 2022-06-30 | -15.51% |
| 2022-03-31 | -39.65% |
| 2021-12-31 | -24.81% |
| 2021-09-30 | -15.08% |
| 2021-06-30 | -12.88% |
| 2021-03-31 | 2.83% |
| 2020-12-31 | -21.08% |
| 2020-09-30 | -18.75% |
| 2020-06-30 | -17.86% |
| 2020-03-31 | -46.76% |
| 2019-12-31 | -40.94% |
| 2019-09-30 | -47.92% |
| 2019-06-30 | -44.38% |
| 2019-03-31 | -35.41% |
| 2018-12-31 | -49.34% |
| 2018-09-30 | -80.85% |
| 2018-06-30 | -125.47% |
| 2018-03-31 | -217.55% |
| 2017-12-31 | -272.82% |
| 2017-09-30 | -356.62% |
| 2017-06-30 | -231.16% |
| 2017-03-31 | -161.13% |
| 2016-12-31 | -128.47% |
| 2016-09-30 | -275.66% |
| 2016-06-30 | -197.51% |
| 2016-03-31 | -155.77% |
| 2015-12-31 | -115.88% |
| 2015-09-30 | -91.70% |
| 2015-06-30 | -72.78% |
| 2015-03-31 | -57.25% |
| 2014-12-31 | -120.26% |
| 2014-09-30 | -77.56% |
| 2014-06-30 | -52.96% |
| 2014-03-31 | -31.42% |
| 2013-12-31 | -64.42% |
| 2013-09-30 | -63.45% |
| 2013-06-30 | -66.92% |
| 2013-03-31 | -62.36% |
| 2012-12-31 | -57.31% |
| 2012-09-30 | -636.80% |
| 2012-06-30 | -127.27% |
| 2012-03-31 | -50.77% |
| 2011-12-31 | -18.53% |
| 2010-12-31 | -3458.01% |
| 2010-09-30 | -650.00% |
| 2010-06-30 | -762.90% |
| 2010-03-31 | -37868.29% |
| 2009-12-31 | -12200.00% |
| 2009-09-30 | -17350.30% |
| 2009-06-30 | -5720.35% |
